Confirming the Diagnosis and Rule-Outs

Because PCDH19-related epilepsy is rare, it is frequently confused with other seizure disorders that begin in infancy. Getting the right diagnosis is a process of narrowing down possibilities, often starting with a comparison to a more well-known condition called Dravet syndrome. While they may look similar at first glance, they have distinct biological “fingerprints” that help doctors tell them apart ^[1][2].

PCDH19 vs. Dravet Syndrome: Tendencies and Overlap

Both conditions involve seizures that are triggered by fever and begin in the first few years of life. However, doctors look for broad tendencies to help differentiate the two. It is crucial to note that there is substantial overlap between these disorders; clinical assessment and genetic testing, not seizure style alone, makes the distinction.

Historically, girls who tested negative for the SCN1A gene (Dravet) were then commonly tested sequentially for PCDH19 ^[6]. Today, current evaluation commonly uses a multigene epilepsy panel or exome/genome testing that evaluates multiple genes at the same time.

The Necessary Genetic Tests

A simple blood or saliva test is used to confirm the diagnosis, but it must look for two different things. If your child’s test only checked one, the diagnosis might have been missed.

1. Sequencing: This “reads” the gene letter-by-letter to look for spelling mistakes (mutations) ^[7].
2. Deletion/Duplication Analysis (CNV): This checks if entire “pages” of the gene are missing or extra. Some children have the correct “spelling” but are missing the gene entirely, which only this test can find ^[6][8].

(Note: A finding of a “Variant of Uncertain Significance” (VUS) does not definitively confirm the diagnosis or direct treatment on its own; it requires clinical correlation.)

Why Parents Are Tested and Genetic Counseling

Once a mutation is found in a child, doctors almost always recommend testing the biological parents, guided by formal genetic counseling. This is about understanding the family’s future risks.

Inheritance Patterns

• The Affected or Carrier Female: A heterozygous female generally has a 50% chance of transmitting the variant in each pregnancy, with variable expression in daughters, and usually no typical symptoms in non-mosaic sons.
• The Asymptomatic Father: In PCDH19, a hemizygous father can carry the mutation on his single X chromosome and have absolutely no symptoms of epilepsy ^[9]. If he is a carrier, he will pass that mutation to all of his daughters and none of his sons ^[9][10].

Looking for Mosaicism

Sometimes, a parent’s standard test comes back negative, but the child still has the mutation. This could be a de novo mutation (a random “typo” that happened at conception). However, it could also be mosaicism ^[11].

Mosaicism means the parent has the mutation in only a small percentage of their cells ^[12]. If those cells are in the father’s sperm or the mother’s eggs (germline mosaicism), they can pass the condition to multiple children. A negative standard blood or saliva test cannot totally eliminate the risk of germline or low-level mosaicism ^[13]. Using highly sensitive testing can help identify these low levels, allowing for more accurate genetic counseling ^[11].

Other “Look-Alikes”

If tests for both SCN1A and PCDH19 are negative, doctors may look for other rare conditions that cause fever-sensitive seizure clusters, such as mutations in the SMC1A, CHD2, or STXBP1 genes ^[14][15]. Each of these has its own unique biological pathway, making genetic clarity the “north star” for your child’s medical team.